Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
History
Social responsibility
Our companies
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A.
Debioclinic S.A.
Debiovision Inc.
Debioinnovation S.A.
Business Model
Strengths
Development capabilites
Preclinical
Clinical
Manufacturing
Regulatory
Innovative drug delivery and formulation
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Commercial Products
Eloxatin®
Decapeptyl®
News & Events
Press Releases
Awards
Publications
Conferences
News
02.09.2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21.08.2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology
Home
News & Events
Publications
Debio 9902 - ZT-1
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
22-Apr-2006
Population Pharmacokinetics of ZT-1 and its active Metabolite Huperzine A after i.v., oral and s.c. Administration in Healthy Volunteers
22-Apr-2006
ZT-1 for the Symptomatic Treatment of Mild to Moderate Alzheimer´s Disease: Preliminary Results of a Multicenter, Randomised, Double-blind Placebo and Active controlled Phase II Study
22-Apr-2006
Preparation of a sustained-release Implant of the Acetylcholinesterase Inhibitor ZT-1 by Hot-Melt Extrusion (HME) and Evaluation in Rats
22-Apr-2006
Reversal of Scopolamine-Related Deficits in Cognitive Functions by ZT-1, A Huperzine-A Derivative
22-Apr-2006
The Prolonged Action of the Acethylcholinesterae Inhibitor ZT-1 after s.c. Injections of Sustained Release Implants in Healthy Volunteers
29-Jun-2004
The Effectiveness of ZT-1 and Donepezil in Reversing Scopolamine-induced Cognitive Impariment in Elderly Volunteers
27-Nov-2003
The sustained release of the acetylcholinesterase inhibitor ZT-1 confers the potential for a more efficient neuroprotection in rats
05-Jun-2003
The Psychopharmacology of Huperzine A: an Alkaloid with Cognitive Enhancing and Neuroprotective Properties of Interest in the Treatment of Alzheimer´s Disease
< Prev
1
Next >
Results 1 - 8 of 8
Debio 025
( 28 items )
Triptorelin / Decapeptyl / Trelstar
( 7 items )
Oxaliplatin – Eloxatin – Elplat
( 12 items )
Debio 8609 Sanvar
( 1 items )
Archives
( 15 items )